Juntendo University · Graduate School of Medicine / Faculty of Medicine

Research keywordssystemic lupus erythematosus・lupus nephritis・autoantibodies・Sjogren syndrome・rheumatoid arthritis・CTGF signaling・osteoclast differentiation

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• 1155/2013/607137. Epub 2013 Aug 22. PubMed PMID: 24058910; PubMed Central PMCID: PMC3766614. #Nozawa K（corresponding author）, Fujishiro M, Kawasaki M, Yamaguchi A, Ikeda K, Morimoto S, Iwabuchi K, Yanagida M, Ichinose S, Morioka M, Ogawa H, Takamori K, Takasaki Y, Sekigawa I. Inhibition of connective tissue growth factor ameliorates disease in a murine model of rheumatoid arthritis. Arthritis Rheum. 2013 Jun;65(6):1477-86. doi:2013
• Bortezomib treatment prevents glomerulosclerosis associated with lupus nephritis in a murine model through suppressive effects on the immune and renin-angiotensin systems.
• 全身性エリテマトーデスの病因・病態/全身性エリテマトーデスのシグナル伝達異常 SLEにおける末梢血リンパ球のCD62L及びケモカインレセプターの発現の検討
• SLE-DAS remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in SLE remission and lupus low disease activity state.

• 血管新生阻害による関節リウマチの新規治療法の開発

• Official profile